Vanda Pharmaceuticals

Squeezing some value from trash stocks

Close to 20 firms, ranging from Acadia Pharmaceuticals Inc. to Vanda Pharmaceuticals, are in this odd situation, and many more aren’t far away Numerous US technology and biotechnology firms are valued at less than the net cash...

US FDA accepts Vanda Pharma's resubmission for iloperidone

Rockville, Maryland Vanda Pharmaceuticals Inc, a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, reported today that the FDA...

FDA accepts Vanda Pharmaceuticals Iloperidone resubmission

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, reported today that the FDA has accepted...

UPDATE 1-Vanda says FDA accepts schizophrenia drug response

Nov 20 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.O: ) said U.S. health regulators accepted the complete response for its experimental schizophrenia drug, iloperidone, sending its shares up 40 percent in pre-market trade. The...

Addiction Therapeutics Reviewed by NeuroInvestment (Marketwire)

Friday November 14, 10:43 am ET CARDIFF, CA--(MARKET WIRE)--Nov 14, 2008 -- NI Research today announced the release of the November issue of NeuroInvestment, featuring a review of pharmacologic therapeutics for addiction. The...

Titan Pharmaceuticals Earnings Call scheduled for 10:00 am ET today (CCBN)

Titan Pharmaceuticals Earnings Conference Call (Q3 2008) Scheduled to start Tue, Nov 11, 2008, 10:00 am Eastern After the event has finished, the audio will be available from this page until Sat, Nov 7, 2009 Titan...

Titan Pharmaceuticals Earnings Call scheduled for Tue, Nov 11 (CCBN)

Titan Pharmaceuticals Earnings Conference Call (Q3 2008) Scheduled to start Tue, Nov 11, 2008, 10:00 am Eastern After the event has finished, the audio will be available from this page until Sat, Nov 7, 2009 Titan...

WRAPUP 1-Small drug developers cut jobs to save cash in crunch

By Esha Dey BANGALORE, Nov 5 (Reuters) - Pharmaceutical companies CombinatoRx Inc and A.P. Pharma Inc on Wednesday became the latest in a series of drug developers to cut jobs, as they focus efforts on near-term value drivers...